Chicago, Illinois
United States
9
2023-10-26
4
2024-04-16
These are the the leading inventors for applications assigned to Exicure Operating Company:
Exicure Operating Company based in Chicago, US has been assigned the rights to these inventions. The list includes both Pending Applications and Patent Grants:
TREATMENT OF SKIN DISEASES AND DISORDERS USING INHIBITORS OF KALLIKREIN-RELATED PEPTIDASES (KLK)
#2 | 2023-10-19TUMOR NECROSIS FACTOR RECEPTOR SUPERFAMILY (TNFRSF) AGONISTS, SPHERICAL NUCLEIC ACID (SNA) TLR9 AGONISTS AND CHECKPOINT INHIBITORS FOR ANTITUMOR THERAPY
#3 | 2022-11-17ADMINISTRATION OF SPHERICAL NUCLEIC ACIDS FOR OPHTHALMOLOGICAL USES
#4 | 2022-11-03LIPOSOMAL SPHERICAL NUCLEIC ACID (SNA) CONSTRUCTS FOR SPLICE MODULATION
#5 | 2022-08-18 ✅ Patent 11,957,788 granted on 2024-04-16Multivalent delivery of immune modulators by liposomal spherical nucleic acids for prophylactic or therapeutic applications
#6 | 2022-03-24COMBINED SPHERICAL NUCLEIC ACID AND CHECKPOINT INHIBITOR FOR ANTITUMOR THERAPY
#7 | 2020-10-01 ✅ Patent 11,866,700 granted on 2024-01-09Liposomal spherical nucleic acid (SNA) constructs presenting antisense oligonucleotides (ASO) for specific knockdown of interleukin 17 receptor mRNA
#8 | 2020-06-18 ✅ Patent 11,696,954 granted on 2023-07-11Synthesis of spherical nucleic acids using lipophilic moieties
#9 | 2020-03-05 ✅ Patent 11,123,294 granted on 2021-09-21Multivalent delivery of immune modulators by liposomal spherical nucleic acids for prophylactic or therapeutic applications
Also check out Exicure Operating Company's (Chicago, United States) applicant profile with 4 patent applications submitted.
321853 ⎘